Innovate Cambridge Summit 2026 highlights innovation leadership and growth
At the Innovate Cambridge Summit 2026, new analysis from Cambridge Innovation Capital showed the average equity raised per deal in life sciences and deep tech has increased five-fold over the last decade, with Cambridge-based early-stage companies raising £9.1 billion in that period. GSK announced it will move its R&D headquarters to Cambridge in 2029, and the University's partnership with IonQ will bring the UK's first commercial scale quantum computer to Cambridge next year. A new task force was announced to develop approaches for keeping companies' operations in the UK even after international acquisition.
